• What healthcare personnel should know about caring for patients with confirmed or possible 2019-nCoV infection Cite CITE Title : What healthcare personnel should know about caring for patients with confirmed or possible 2019-nCoV infection Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division. Published Date : February 7, 2020 Series : 2019 novel coronavirus URL : https://stacks.cdc.gov/view/cdc/84966 National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division. (2020). What healthcare personnel should know about caring for patients with confirmed or possible 2019-nCoV infection. National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division. "What healthcare personnel should know about caring for patients with confirmed or possible 2019-nCoV infection" (2020) National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division. "What healthcare personnel should know about caring for patients with confirmed or possible 2019-nCoV infection" , 2020 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 51.88 KB] : National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division. February 7, 2020 | 2019 novel coronavirus Description: Healthcare personnel (HCP) are on the front lines of caring for patients with confirmed or possible infection with 2019 novel coronavirus (2019-nCoV) ... File Type: [PDF - 51.88 KB] File Type: [PDF - 51.88 KB] 2019-nCoV situation summary 2019 novel coronavirus (2019-nCoV) in the U.S. updated February 7, 2020 Cite CITE Title : 2019-nCoV situation summary 2019 novel coronavirus (2019-nCoV) in the U.S. updated February 7, 2020 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : February 7, 2020 Series : 2019 novel coronavirus URL : https://stacks.cdc.gov/view/cdc/84972 Centers for Disease Control and Prevention (U.S.) (2020). 2019-nCoV situation summary 2019 novel coronavirus (2019-nCoV) in the U.S. updated February 7, 2020. Centers for Disease Control and Prevention (U.S.) "2019-nCoV situation summary 2019 novel coronavirus (2019-nCoV) in the U.S. updated February 7, 2020" (2020) Centers for Disease Control and Prevention (U.S.) "2019-nCoV situation summary 2019 novel coronavirus (2019-nCoV) in the U.S. updated February 7, 2020" , 2020 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 394.75 KB] : Centers for Disease Control and Prevention (U.S.) February 7, 2020 | 2019 novel coronavirus Description: This is an emerging, rapidly evolving situation and CDC will provide updated information as it becomes available, in addition to updated guidance.Upda... File Type: [PDF - 394.75 KB] File Type: [PDF - 394.75 KB] Interim considerations for disposition of hospitalized patients with 2019-nCoV infection Cite CITE Title : Interim considerations for disposition of hospitalized patients with 2019-nCoV infection Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division. Published Date : February 8, 2020 Series : 2019 novel coronavirus URL : https://stacks.cdc.gov/view/cdc/84974 National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division. (2020). Interim considerations for disposition of hospitalized patients with 2019-nCoV infection. National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division. "Interim considerations for disposition of hospitalized patients with 2019-nCoV infection" (2020) National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division. "Interim considerations for disposition of hospitalized patients with 2019-nCoV infection" , 2020 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 59.42 KB] : National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division. February 8, 2020 | 2019 novel coronavirus Description: Currently, limited information is available to characterize the spectrum of clinical illness, transmission efficiency, and the duration of viral shedd... File Type: [PDF - 59.42 KB] File Type: [PDF - 59.42 KB] Interim guidance for emergency medical services (EMS) systems and 911 public safety answering points (PSAPs) for 2019-nCoV in the United States Cite CITE Title : Interim guidance for emergency medical services (EMS) systems and 911 public safety answering points (PSAPs) for 2019-nCoV in the United States Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division. Published Date : February 6, 2020 Series : 2019 novel coronavirus URL : https://stacks.cdc.gov/view/cdc/84967 National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division. (2020). Interim guidance for emergency medical services (EMS) systems and 911 public safety answering points (PSAPs) for 2019-nCoV in the United States. National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division. "Interim guidance for emergency medical services (EMS) systems and 911 public safety answering points (PSAPs) for 2019-nCoV in the United States" (2020) National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division. "Interim guidance for emergency medical services (EMS) systems and 911 public safety answering points (PSAPs) for 2019-nCoV in the United States" , 2020 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 88.34 KB] : National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division. February 6, 2020 | 2019 novel coronavirus Description: Emergency medical services (EMS) play a vital role in responding to requests for assistance, triaging patients, and providing emergency medical treatm... File Type: [PDF - 88.34 KB] File Type: [PDF - 88.34 KB] Interim guidance for businesses and employers to plan and respond to 2019 novel coronavirus (2019-nCoV), February 2020 Cite CITE Title : Interim guidance for businesses and employers to plan and respond to 2019 novel coronavirus (2019-nCoV), February 2020 Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division. Published Date : February 7, 2020 Series : 2019 novel coronavirus URL : https://stacks.cdc.gov/view/cdc/84965 National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division. (2020). Interim guidance for businesses and employers to plan and respond to 2019 novel coronavirus (2019-nCoV), February 2020. National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division. "Interim guidance for businesses and employers to plan and respond to 2019 novel coronavirus (2019-nCoV), February 2020" (2020) National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division. "Interim guidance for businesses and employers to plan and respond to 2019 novel coronavirus (2019-nCoV), February 2020" , 2020 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 86.38 KB] : National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division. February 7, 2020 | 2019 novel coronavirus Description: This interim guidance is based on what is currently known about the 2019 novel coronavirus (2019-nCoV). The Centers for Disease Control and Prevention... File Type: [PDF - 86.38 KB] File Type: [PDF - 86.38 KB] Confirmed 2019-nCoV cases globally : global map : as of 11:00 a.m. ET February 7, 2020 Cite CITE Title : Confirmed 2019-nCoV cases globally : global map : as of 11:00 a.m. ET February 7, 2020 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : February 7, 2020 Series : 2019 novel coronavirus URL : https://stacks.cdc.gov/view/cdc/84970 Centers for Disease Control and Prevention (U.S.) (2020). Confirmed 2019-nCoV cases globally : global map : as of 11:00 a.m. ET February 7, 2020. Centers for Disease Control and Prevention (U.S.) "Confirmed 2019-nCoV cases globally : global map : as of 11:00 a.m. ET February 7, 2020" (2020) Centers for Disease Control and Prevention (U.S.) "Confirmed 2019-nCoV cases globally : global map : as of 11:00 a.m. ET February 7, 2020" , 2020 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 186.74 KB] : Centers for Disease Control and Prevention (U.S.) February 7, 2020 | 2019 novel coronavirus Description: Locations with Confirmed 2019-nCoV Cases File Type: [PDF - 186.74 KB] File Type: [PDF - 186.74 KB] 2019 novel coronavirus cases in the U.S. : updated February 7, 2020 Cite CITE Title : 2019 novel coronavirus cases in the U.S. : updated February 7, 2020 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : February 7, 2020 Series : 2019 novel coronavirus URL : https://stacks.cdc.gov/view/cdc/84971 Centers for Disease Control and Prevention (U.S.) (2020). 2019 novel coronavirus cases in the U.S. : updated February 7, 2020. Centers for Disease Control and Prevention (U.S.) "2019 novel coronavirus cases in the U.S. : updated February 7, 2020" (2020) Centers for Disease Control and Prevention (U.S.) "2019 novel coronavirus cases in the U.S. : updated February 7, 2020" , 2020 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 510.03 KB] : Centers for Disease Control and Prevention (U.S.) February 7, 2020 | 2019 novel coronavirus Description: CDC is closely monitoring an outbreak of respiratory illness caused by a novel (new) coronavirus named 2019-nCoV. The outbreak first started in Wuhan,... File Type: [PDF - 510.03 KB] File Type: [PDF - 510.03 KB] CDC grows 2019-nCoV virus in cell culture Cite CITE Title : CDC grows 2019-nCoV virus in cell culture Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division. Published Date : February 6, 2020 Series : 2019 novel coronavirus URL : https://stacks.cdc.gov/view/cdc/84968 National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division. (2020). CDC grows 2019-nCoV virus in cell culture. National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division. "CDC grows 2019-nCoV virus in cell culture" (2020) National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division. "CDC grows 2019-nCoV virus in cell culture" , 2020 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 45.10 KB] : National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division. February 6, 2020 | 2019 novel coronavirus Description: Virus isolates will be used for research by the scientific and medical communityOne important way that CDC is supporting global efforts to study and l... File Type: [PDF - 45.10 KB] File Type: [PDF - 45.10 KB]

More +